Jci_page_head_homepage_01 Jci_page_head_homepage_02
Craig Brooks, Qingqing Wei, Sung-Gyu Cho, Zheng Dong
Published in Volume 119, Issue 5
J Clin Invest. 2009; 119(5):1275–1285 doi:10.1172/JCI37829
Abstract | Full text | PDF | Supplemental material
Options: View larger image (or click on image)
Medium
Figure 5
Inhibition of cytochrome c release during ATP depletion by DN-Drp1.

RPTCs were cotransfected with MitoRed and DN-Drp1 or empty vector and then treated with 10 mM azide for 3 hours. The cells were fixed for immunofluorescence of cytochrome c or Bax. The examination was focused on the transfected (MitoRed labeled) cells to determine the effects of DN-Drp1. (A) Representative images of MitoRed and cytochrome c staining. The staining was examined by confocal microscopy in the same cells. In untreated cells (control), cytochrome c staining colocalized with MitoRed in filamentous mitochondria. Following azide treatment, mitochondria in vector-transfected cells became fragmented and cytochrome c was released into the cytosol. Cells transfected with DN-Drp1 retained their filamentous mitochondria, and cytochrome c was retained in mitochondria. Scale bars: 5 μm. (B) Quantification of the effects of DN-Drp1 on cytochrome c release. The localization of cytochrome c in MitoRed-transfected cells was evaluated to determine the percentage of cells that released cytochrome c into cytosol. (C) Quantification of the effects of DN-Drp1 on Bax translocation to mitochondria. The localization of Bax in MitoRed-transfected cells was evaluated to determine the percentage of cells that showed Bax accumulation in mitochondria. Data in B and C are presented as mean ± SD; n ≥ 3. *P < 0.05, significantly different from untreated control; #P < 0.05, significantly different from azide-treated cells that were transfected with empty vector.